APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
63 hedge funds and large institutions have $148M invested in Aptose Biosciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
53% less capital invested
Capital invested by funds: $313M → $148M (-$165M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
63
Holding in Top 10
1
Calls
$447K
Puts
$516K
Top Buyers
| 1 | +$5.28M | |
| 2 | +$3.36M | |
| 3 | +$3M | |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
+$1.66M |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$508K |
Top Sellers
| 1 | -$16.1M | |
| 2 | -$9.59M | |
| 3 | -$8.42M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$6.59M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$4.16M |